PAG
MRNA icon

Private Advisor Group’s Moderna MRNA Stock Holding History

Private Advisor Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-600
Closed -$4.14K – 2751
2026
Q1 		$4.14K Buy
+600
New +$28K ﹤0.01% 2664
2021
Q1 		– Sell
-1,000
Closed -$3K – 1941
2020
Q4 		$3K Buy
+1,000
New +$101K ﹤0.01% 1769

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Private Advisor Group's MRNA Position: Q2 2026 in Review

Private Advisor Group reduced its Moderna (MRNA) stake by 6.2% in Q2 2026, selling an estimated $21.7K and leaving 6,392 shares worth $448K. The position accounts for ﹤0.01% of the portfolio, ranked #1870.

Private Advisor Group first reported a position in MRNA in Q1 2020 and has held it in 26 quarters since. The position peaked at $14.2M in Q3 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Private Advisor Group held 6,392 shares of Moderna worth $448K as of Q2 2026.
  • Private Advisor Group sold 420 Moderna shares in Q2 2026, an estimated $21.7K.
  • Moderna made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #1870 holding.
  • Private Advisor Group first reported a position in Moderna in Q1 2020 and has held it in 26 quarters since.
  • Private Advisor Group's Moderna position peaked at $14.2M in Q3 2021.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.